Quantitative AFM analysis of phase separated borosilicate glass surfaces

Phase separated borosilicate glass samples were prepared by applying various heat treatments. Using selective chemical etching we performed AFM measurement on the phase separated glass surfaces. A quantitative roughness analysis allowed us to measure precisely the dependence of the characteristic size of the phase domains on heating time and temperature. The experimental measurements are very well described by the theoretically expected scaling laws. Interdiffusion coefficients and activation energy are estimated from this analysis and are consistent with literature data

The fundamental group and torsion group of Beauville surfaces

We give a survey on the fundamental group of surfaces isogenous to a higher product. If the surfaces are regular, e.g. if they are Beauville surfaces, the first homology group is a finite group. We present a MAGMA script which calculates the first homology groups of regular surfaces isogenous to a product.Comment: 14 pages; MAGMA script included; v2: minor corrections, final version to appear in the Proceedings of the Conference "Beauville Surfaces and Groups", Newcastle University (UK), 7-9th June 201

Magnetization profiles and NMR spectra of doped Haldane chains at finite temperatures

Open segments of S=1 antiferromagnetic spin chains are studied at finite temperatures and fields using continuous time Quantum Monte Carlo techniques. By calculating the resulting magnetization profiles for a large range of chain lengths with fixed field and temperature we reconstruct the experimentally measured NMR spectrum of impurity doped Y$_2$BaNi$_{1-x}$Mg$_x$O$_5$. For temperatures above the gap the calculated NMR spectra are in excellent agreement with the experimental results, confirming the existence of $S=1/2$ excitations at the end of open S=1 chain segments. At temperatures below the gap, neglecting inter chain couplings, we still find well defined peaks in the calculated NMR spectra corresponding to the $S=1/2$ chain end excitations. At low temperatures, inter chain couplings could be important, resulting in a more complicated phase.Comment: 7 pages, 5 figures, minor correction

Health related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomised multinational trial: the INITIO-QoL Substudy

The health-related quality of life (HRQoL) outcomes in HIV-infected, treatment-naive patients starting different HAART regimens in a 3-year, randomized, multinational trial were compared. HRQoL was measured in a subgroup of patients enrolled in the INITIO study (153/911), using a modified version of the MOS-HIV questionnaire. The regimens compared in the INITIO trial were composed by two NRTIs (didanosine + stavudine) plus either an NNRTI (efavirenz) or a PI (nelfinavir), or both (efavirenz + nelfinavir). Primary HRQoL outcomes were Physical and Mental Health Summary scores (PHS and MHS, respectively). During follow-up, an increase of PHS score was observed in all treatment arms. The MHS score remained substantially unchanged with the four-drug combination and showed with both NNRTI- and PI-based three-drug regimens a marked trend toward improvement, which became statistically significant when a multiple imputation method was used to adjust for missing data. Overall, starting all the combination regimens compared in the INITIO study was associated with a maintained or slightly improved HRQOL status, consistently with the positive immunological and virological changes observed in the main study. The observed differences in the MHS indicate a possible HRQoL benefit associated to the use of three-drug, two-class regimens and no additional benefit for the use of four-drug, three-class regimens, confirming that three-drug, two-class regimens that include two NRTIs plus either an NNRTI or a PI should be preferred as initial treatment of HIV infection

Density-Matrix Renormalization-Group Analysis of Quantum Critical Points: I. Quantum Spin Chains

We present a simple method, combining the density-matrix renormalization-group (DMRG) algorithm with finite-size scaling, which permits the study of critical behavior in quantum spin chains. Spin moments and dimerization are induced by boundary conditions at the chain ends and these exhibit power-law decay at critical points. Results are presented for the spin-1/2 Heisenberg antiferromagnet; an analytic calculation shows that logarithmic corrections to scaling can sometimes be avoided. We also examine the spin-1 chain at the critical point separating the Haldane gap and dimerized phases. Exponents for the dimer-dimer and the spin-spin correlation functions are consistent with results obtained from bosonization.Comment: 21 pages, 12 figures, new results and added references, to appear in PR

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.

OBJECTIVE: Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor expressed in tissues with high oxidative activity that plays a central role in metabolism. In this work, we investigated the effect of hepatocyte PPARα on non-alcoholic fatty liver disease (NAFLD). DESIGN: We constructed a novel hepatocyte-specific PPARα knockout (Pparα(hep-/-)) mouse model. Using this novel model, we performed transcriptomic analysis following fenofibrate treatment. Next, we investigated which physiological challenges impact on PPARα. Moreover, we measured the contribution of hepatocytic PPARα activity to whole-body metabolism and fibroblast growth factor 21 production during fasting. Finally, we determined the influence of hepatocyte-specific PPARα deficiency in different models of steatosis and during ageing. RESULTS: Hepatocyte PPARα deletion impaired fatty acid catabolism, resulting in hepatic lipid accumulation during fasting and in two preclinical models of steatosis. Fasting mice showed acute PPARα-dependent hepatocyte activity during early night, with correspondingly increased circulating free fatty acids, which could be further stimulated by adipocyte lipolysis. Fasting led to mild hypoglycaemia and hypothermia in Pparα(hep-/-) mice when compared with Pparα(-/-) mice implying a role of PPARα activity in non-hepatic tissues. In agreement with this observation, Pparα(-/-) mice became overweight during ageing while Pparα(hep-/-) remained lean. However, like Pparα(-/-) mice, Pparα(hep-/-) fed a standard diet developed hepatic steatosis in ageing. CONCLUSIONS: Altogether, these findings underscore the potential of hepatocyte PPARα as a drug target for NAFLD

S=1/2S=1/2 Chain-Boundary Excitations in the Haldane Phase of 1D S=1S=1 Systems

The $s=1/2$ chain-boundary excitations occurring in the Haldane phaseof $s=1$ antiferromagnetic spin chains are investigated. The bilinear-biquadratic hamiltonian is used to study these excitations as a function of the strength of the biquadratic term, $\beta$, between $-1\le\beta\le1$. At the AKLT point, $\beta=-1/3$, we show explicitly that these excitations are localized at the boundaries of the chain on a length scale equal to the correlation length $\xi=1/\ln 3$, and that the on-site magnetization for the first site is $=2/3$. Applying the density matrixrenormalization group we show that the chain-boundaryexcitations remain localized at the boundaries for $-1\le\beta\le1$. As the two critical points $\beta=\pm1$ are approached the size of the $s=1/2$ objects diverges and their amplitude vanishes.Comment: 4 Pages, 4 eps figures. Uses RevTeX 3.0. Submitted to PR

New frontiers on adjuvants drug strategies and treatments in periodontitis

Causes of the progression of periodontitis such as an imbalance between the immune response by the host by the release of inflammatory mediators in the response of the oral pathogenic dysbiotic biofilm have been identified. New insights on specific cell signaling pathways that appear during periodontitis have attracted the attention of researchers in the study of new personalised approaches for the treatment of periodontitis. The gold standard of non‐surgical therapy of perio-dontitis involves the removal of supra and subgingival biofilm through professional scaling and root planing (SRP) and oral hygiene instructions. In order to improve periodontal clinical outcomes and overcome the limitations of traditional SRP, additional adjuvants have been developed in recent decades, including local or systemic antibiotics, antiseptics, probiotics, anti‐inflammatory and anti-resorptive drugs and host modulation therapies. This review is aimed to update the current and recent evolution of therapies of management of periodontitis based on the adjunctive and target therapies. Moreover, we discuss the advances in host modulation of periodontitis and the impact of targeting epigenetic mechanisms approaches for a personalised therapeutic success in the management of periodontitis. In conclusion, the future goal in periodontology will be to combine and personalise the periodontal treatments to the colonising microbial profile and to the specific response of the individual patient